Fan, Zhenziang
Kernan, Kate F.
Qin, Yidi
Canna, Scott
Berg, Robert A.
Wessel, David
Pollack, Murray M.
Meert, Kathleen
Hall, Mark
Newth, Christopher
Lin, John C.
Doctor, Allan
Shanley, Tom
Cornell, Tim
Harrison, Rick E.
Zuppa, Athena F.
Sward, Katherine
Dean, J. Michael
Park, H. J.
Carcillo, Joseph A.
Funding for this research was provided by:
National Institutes of General Medical Sciences (1K23GM148827-01, R01GM108618, R01GM108618)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (U10HD050096, U10HD049981, U10HD049981, U10HD063108, U10HD63106, U10HD063114, U10HD050012, U01HD049934)
National Institutes of Child Health and Human Development (5U01HD049934-10S1)
Article History
Received: 13 June 2023
Accepted: 27 August 2023
First Online: 6 September 2023
Declarations
:
: The study was approved by the Institutional Review Board at University of Utah Central IRB #70976.
: Not applicable.
: The authors had no competing interest but they did have the following. Authors Carcillo, Berg, Wessel, Pollack, Meert, Hall, Newth, Doctor, Shanley, Cornell, Harrison, Zuppa, and Dean received support for article research from the NICHD. Dr. Carcillo and Dr Park’s institutions also received funding from the National Institute of General Medical Sciences. Dr. Pollack disclosed that his research is supported by philanthropy from Mallinckrodt Pharmaceuticals. Dr. Hall received funding from LaJolla Pharmaceuticals (service as a consultant), unrelated to the current submission. Dr. Newth received funding from Philips Research North America. Dr. Doctor’s institution received funding from the Department of Defense and Kalocyte. Dr. Shanley received funding from Springer publishing, International Pediatric Research Foundation, and Pediatric Academic Societies. Dr. Cornell disclosed he is co-founder of Pre-Dixon Bio. The remaining authors have disclosed that they do not have any potential conflicts of interest.